PRINCETON, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc. a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced the launch of a new tool to help healthcare providers (HCPs) navigate the complicated process of accurately staging patients with Mycosis Fungoides (MF) or Sézary Syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma (CTCL). The tool is now live on PROBEinCTCL.com alongside comprehensive information and resources about CTCL. “CTCL is a rare form of blood cance ...